CD274 and breast cancer: The comparison between three PDL1 signatures revealed a stronger cytotoxic profile correlated with anti-tumor pathways activation (IFNα and IFNγ) in breast cancers and GISTs, suggesting a sustained activation of anti-tumor T-cells in breast cancers and GISTs of good prognosis.